EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models

Cristian A Droppelmann, Danae Campos-Melo, Veronica Noches, Crystal McLellan, Robert Szabla, Taylor A Lyons, Hind Amzil, Benjamin Withers, Brianna Kaplanis, Kirti S Sonkar, Anne Simon, Emanuele Buratti und 3 weitere

Brain · 2024

DOI: 10.1093/brain/awae078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Cristian A Droppelmann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5C1, Canada. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Disease Models, Animal, Guanine Nucleotide Exchange Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Temerty Family Foundation, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggregation of the RNA-binding protein TAR DNA binding protein (TDP-43) is a hallmark of TDP-proteinopathies including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). As TDP-43 aggregation and dysregulation are causative of neuronal death, there is a special interest in targeting this protein as a therapeutic approach. Previously, we found that TDP-43 extensively co-aggregated with the dual function protein GEF (guanine exchange factor) and RNA-binding protein rho guanine nucleotide exchange factor (RGNEF) in ALS patients. Here, we show that an N-terminal fragment of RGNEF (NF242) interacts directly with the RNA recognition motifs of TDP-43 competing with RNA and that the IPT/TIG domain of NF242 is essential for this interaction. Genetic expression of NF242 in a fruit fly ALS model overexpressing TDP-43 suppressed the neuropathological phenotype increasing lifespan, abolishing motor defects and preventing neurodegeneration. Intracerebroventricular injections of AAV9/NF242 in a severe TDP-43 murine model (rNLS8) improved lifespan and motor phenotype, and decreased neuroinflammation markers. Our results demonstrate an innovative way to target TDP-43 proteinopathies using a protein fragment with a strong affinity for TDP-43 aggregates and a mechanism that includes competition with RNA sequestration, suggesting a promising therapeutic strategy for TDP-43 proteinopathies such as ALS and FTD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDNA-Binding ProteinsDisease Models, AnimalGuanine Nucleotide Exchange FactorsPhenotypeAnimalsMiceHumansDrosophilaMice, TransgenicDrosophila ProteinsMale

Stichwörter der Autor:innen

RNA binding proteinsRNA metabolismamyotrophic lateral sclerosismotor neuron diseaseneuronal cytoplasmic inclusionstherapeutic

Substanzen

DNA-Binding ProteinsGuanine Nucleotide Exchange FactorsTARDBP protein, humanTardbp protein, mouseDrosophila Proteins

Autor:innen und Institutionen

  • Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5C1, Canada.
  • Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5C1, Canada.
  • International Centre for Genetic Engineering and Biotechnology (ICGEB), AREA Science Park, 34149 Trieste, Italy.
  • Department of Biology, Faculty of Science, Western University, London, Ontario N6A 5B7, Canada.
  • Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5C1, Canada.

ORCID-Profile: Michael J Strong

Förderung

  • NIH HHS
  • Temerty Family Foundation
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Droppelmann, C. A., Campos-Melo, D., Noches, V., McLellan, C., Szabla, R., Lyons, T. A., Amzil, H., Withers, B., Kaplanis, B., Sonkar, K. S., Simon, A., Buratti, E., Junop, M., Kramer, J. M., & Strong, M. J. (2024). Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models. Brain. https://doi.org/10.1093/brain/awae078

Vancouver

Droppelmann CA, Campos-Melo D, Noches V, McLellan C, Szabla R, Lyons TA, et al. Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models. Brain. 2024. doi:10.1093/brain/awae078

BibTeX
@article{Droppelmann2024,
  author = {Droppelmann, Cristian A and Campos-Melo, Danae and Noches, Veronica and McLellan, Crystal and Szabla, Robert and Lyons, Taylor A and Amzil, Hind and Withers, Benjamin and Kaplanis, Brianna and Sonkar, Kirti S and Simon, Anne and Buratti, Emanuele and Junop, Murray and Kramer, Jamie M and Strong, Michael J},
  title = {Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae078}
}
Kostenlos starten →